{
    "pmcid": "7844813",
    "qa_pairs": {
        "What is one advantage of nanobodies over conventional antibodies mentioned in the study?": [
            "Better tissue penetration and administration via nasal spray",
            "Longer circulation half-life",
            "Higher molecular weight",
            "Requirement for post-translational modifications"
        ],
        "What is the source of the na\u00efve VHH library used to screen for nanobodies targeting the spike protein of SARS-CoV-2?": [
            "Bactrian camel blood",
            "Dromedary camel blood",
            "Llama blood",
            "Alpaca blood"
        ],
        "What potential form of administration is suggested for multivalent nanobodies to prevent COVID-19?": [
            "Aerosolized inhalation products",
            "Intravenous injection",
            "Oral tablets",
            "Topical creams"
        ],
        "What was the IC50 value of the heterodimer Nb91-Nb3-hFc against pseudotyped SARS-CoV-2?": [
            "1.54 nM",
            "54.07 nM",
            "32.36 nM",
            "10.25 nM"
        ],
        "Which nanobodies demonstrated significant binding to the RBD and neutralized SARS-CoV-2 pseudotyped viruses in vitro?": [
            "Nb91-hFc and Nb3-hFc",
            "Nb12-hFc and Nb5-hFc",
            "Nb7-hFc and Nb4-hFc",
            "Nb10-hFc and Nb8-hFc"
        ]
    }
}